Navigation Links
BioStorage Technologies Showcases First-Ever Mobile Biorepository - Relofleet™ at Drug Information Association Annual Meeting
Date:6/13/2011

INDIANAPOLIS, June 13, 2011 /PRNewswire/ -- At this year's Drug Information Association Annual Meeting (DIA), BioStorage Technologies will showcase Relofleet™ - the first mobile biorepository designed specifically for sample relocation within North America. This novel sample transport technology allows for the customized transportation of entire sample inventories and associated equipment, while assuring the shipment reaches its destination on time and in optimal condition.

The custom-made, 53-foot trailer accommodates all temperatures from frozen to room temperature and is capable of simultaneously transporting a multitude of biomaterials, clinical trial samples, API and manufactured drugs. Equipped with redundant generator systems, the unit also allows BioStorage Technologies to transport freezers and refrigerators with or without samples.

Relofleet contains a built-in, mobile workstation that conforms to FDA 21 CFR Part 11 compliance standards and provides audit tracking of samples from site-to-site within the BioStorage Technologies ISSIS (Intelligent Specimen Inventory Storage System) database. Sample asset security is provided in-transit via 360 degree internal and external tracking and monitoring provided by 12 security cameras.

"Designed to respond to a growing need for compliant and cost-effective solutions for shipping temperature-sensitive biological samples and materials, Relofleet is the first of its kind," said Russ Hager, Global Director of Supply Chain, BioStorage Technologies.

"With its multiple uses and innovative technology, Relofleet allows our specialized team of logistics experts to provide door-to-door, full-scale support during the entire sample lifecycle management process."

As with all of BioStorage Technologies' processes and systems, Relofleet is validated to adhere to U.S. Food and Drug Administration regulations and the U.S. Department of Transportation g
'/>"/>

SOURCE BioStorage Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioStorage Technologies Partners with Susan G. Komen for the Cure(R) Tissue Bank at the IU Simon Cancer Center in Breast Cancer Research Initiative
2. BioStorage Technologies, Inc. Promotes Lori Ball to Senior Vice President and Expands Role
3. BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference
4. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
5. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
6. BioStorage Technologies Brings Together Industry Leaders for Global Sample Management Benchmarking Symposium
7. BioStorage Technologies Appoints New Vice President of Global Sales
8. BioStorage Technologies Introduces New Version of Web-based Tracking and Sample Management System - ISISS®
9. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium in Conjunction with Biorepositories Asia Conference
10. AMDeCs Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services
11. BioStorage Technologies Appoints New Director of Business Development for European Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Reports from CDC show ... from one or more chronic health conditions - including ... address some of these diseases, but may not eliminate ... face. While implanted nerve stimulation devices today offer relief, ... which can induce side effects. , To eliminate ...
(Date:12/19/2014)... With only 2 weeks left of 2014, ... Biohit products . The product specials include Buy 1 ... Trade-in Program, and free pipette tips. , Sartorius mLINE ... world. They are ideal for lab technicians performing long ... ,     Full volume range of 0.1 uL to 10 ...
(Date:12/19/2014)... YORK , Dec. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced the ... today. "This was a transformational year in ... promising future for our company," said Sergio Traversa ... year, we have executed on key financial, human resource ...
(Date:12/17/2014)... Achim Noack has been named global vice president ... position, Noack will assist Jerry Stoller, CEO and president ... and supervise global marketing management and implementation of new ... and experience in the crop protection industry,” says Jerry ... thinking will be a great asset for Stoller Group, ...
Breaking Biology Technology:Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2
... China, FORT LAUDERDALE, Fla., Sept. 5 ... pioneer in laser,optical breast cancer imaging systems, has ... Tianjin Medical University,s Cancer Institute and,Hospital, the largest ... http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ) Research at the Cancer ...
... EDMONTON, Sept. 5 /PRNewswire-FirstCall/ - Biomira Inc. (Nasdaq: ... of three-year survival results,from a randomized Phase II ... lung cancer (NSCLC). The results suggest that Stimuvax,combined ... benefits to,patients with unresectable stage IIIB NSCLC who ...
... FRANCISCO, Calif., Sept. 5 Hyperion,Therapeutics, a biopharmaceutical ... and hepatology therapies for the,treatment of Urea Cycle ... $40 million Series B financing. Leading the round ... Partners and,NEA, all of Menlo Park, CA. WRF ...
Cached Biology Technology:Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System 2Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System 3Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer 2Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer 3Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer 4Hyperion Therapeutics Secures $40 Million In Series B Round 2
(Date:12/10/2014)... WINSTON-SALEM, N.C. , Dec. 9, 2014  Wake Forest ... medical education building for its School of Medicine. Funding ... a larger capital campaign that will be publicly launched ... will be located in the former 60 series R.J. ... Forest Innovation Quarter. Construction will begin immediately with plans ...
(Date:12/10/2014)... , Dec. 08, 2014 Research and Markets ... addition of the "Biometrics Market in Japan ... http://photos.prnewswire.com/prnh/20130307/600769 The ... such as rural banking and upgradation of the ... witnessed in the market. Besides the aforementioned projects, ...
(Date:12/5/2014)... 4, 2014 Increased emphasis on product ... new testing and inspection technologies. The convergence of ... a range of innovative test solutions. This trend ... Y, which is generally more inclined towards communication, ... development strategies of test equipment vendors will cater ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... follows form" might have been written to describe proteins, ... nature,s workhorse biomolecules enables each to carry out its ... X-ray protein crystallography, in which a beam of x-rays ... protein,s atoms, creating a diffraction pattern of dots that ...
... prescribed drugs for the treatment of heart failure are beta-blockers ... the heart,s workload. The drugs were thought to produce those ... study led by scientists at Temple University School of Medicine, ... counteracting the effects of an enzyme known as GRK2. The ...
... Nov. 5, 2013  The AVS has selected its major award ... to encourage excellence in research and innovation in technical areas ... award winners: Medard W. Welch Award— Dr. ... Barbara, "For seminal contributions to the theory of heterojunctions and ...
Cached Biology News:Bringing out the best in X-ray crystallography data 2Temple researchers uncover clues to how existing heart drugs work 2AVS Announces Its Major Award Winners of 2013 2AVS Announces Its Major Award Winners of 2013 3AVS Announces Its Major Award Winners of 2013 4AVS Announces Its Major Award Winners of 2013 5AVS Announces Its Major Award Winners of 2013 6
... is a commonly used technique for studying ... are electrophoresed on SDS-PAGE and transferred to ... where they are probed with specific antibodies. ... reuse of Southern and Northern blots, it ...
... Custom peptide microarrays designed for quantitative ... samples and built on the flexible ... Thousands of customer specified sequences can ... can provide assistance with custom sequence ...
... Chemicon Select Tissue Arrays are intended for ... tissues were fixed in neutral buffered formalin ... and diagnosis was performed by certified pathologists. ... paraffin blocks and relocated into a new ...
... normal Mega Western Protein Array was developed ... Western Protein Arrays are manufactured using high ... sources. A protein sample from each of ... a Protein molecular weight marker on a ...
Biology Products: